APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA Oligonucleotide Synthesis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DNA Oligonucleotide Synthesis Service Market Analysis and Forecast 2026-2032

Report ID 174571450512 August 2026187 pages

Choose your research edition.

Industry ResearchDNA Oligonucleotide Synthesis Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Oligonucleotide Synthesis Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal DNA Oligonucleotide Synthesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Oligonucleotide Synthesis Service Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Oligonucleotide Synthesis Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global DNA Oligonucleotide Synthesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for DNA Oligonucleotide Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA Oligonucleotide Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DNA Oligonucleotide Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA Oligonucleotide Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of DNA Oligonucleotide Synthesis Service include Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs, Bio Basic, Kaneka Eurogentec SA, AltaBioscience and Synbio Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for DNA Oligonucleotide Synthesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA Oligonucleotide Synthesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Oligonucleotide Synthesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Oligonucleotide Synthesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Oligonucleotide Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Oligonucleotide Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.

DNA Oligonucleotide Synthesis Service Segment by Company

Genewiz

Eurofins Genomics

Gene Oracle

SBS Genetech

Creative Biolabs

Bio Basic

Kaneka Eurogentec SA

AltaBioscience

Synbio Technologies

TriLink

Azenta Life Science

KareBay Biochem

Creative Biogene

Generi Biotech

Primetech

General Biosystems

GenScript

OriGene

BBI

DNA Oligonucleotide Synthesis Service Segment by Type

Standard Oligonucleotides

Micro-Oligonucleotides

Large-scale Oligonucleotides

Degenerate Primers

Long Oligos Synthesis

DNA Oligonucleotide Synthesis Service Segment by Application

Commercial

Academic Research

DNA Oligonucleotide Synthesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Oligonucleotide Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Oligonucleotide Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Oligonucleotide Synthesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of DNA Oligonucleotide Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of DNA Oligonucleotide Synthesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Oligonucleotide Synthesis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Oligonucleotide Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Standard Oligonucleotides Major Player Table 3. Micro-Oligonucleotides Major Player Table 4. Large-scale Oligonucleotides Major Player Table 5. Degenerate Primers Major Player Table 6. Long Oligos Synthesis Major Player Table 7. Global DNA Oligonucleotide Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Commercial Major Player Table 9. Academic Research Major Player Table 10. DNA Oligonucleotide Synthesis Service Industry Trends Table 11. DNA Oligonucleotide Synthesis Service Industry Drivers Table 12. DNA Oligonucleotide Synthesis Service Industry Opportunities and Challenges Table 13. DNA Oligonucleotide Synthesis Service Industry Restraints Table 14. Global DNA Oligonucleotide Synthesis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global DNA Oligonucleotide Synthesis Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global DNA Oligonucleotide Synthesis Service Market Share by Region (2021-2026) Table 17. Global DNA Oligonucleotide Synthesis Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global DNA Oligonucleotide Synthesis Service Market Share by Region (2027-2032) Table 19. Global DNA Oligonucleotide Synthesis Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Players (2021-2026) Table 21. Global DNA Oligonucleotide Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global DNA Oligonucleotide Synthesis Service Key Players Headquarters & Area Served Table 23. Global DNA Oligonucleotide Synthesis Service Players, Product Type & Application Table 24. Global DNA Oligonucleotide Synthesis Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global DNA Oligonucleotide Synthesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global DNA Oligonucleotide Synthesis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Type (2021-2026) Table 31. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Type (2027-2032) Table 32. Global DNA Oligonucleotide Synthesis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Application (2021-2026) Table 36. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Application (2027-2032) Table 37. Genewiz Company Information Table 38. Genewiz Business Overview Table 39. Genewiz DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio Table 41. Genewiz Recent Development Table 42. Eurofins Genomics Company Information Table 43. Eurofins Genomics Business Overview Table 44. Eurofins Genomics DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio Table 46. Eurofins Genomics Recent Development Table 47. Gene Oracle Company Information Table 48. Gene Oracle Business Overview Table 49. Gene Oracle DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio Table 51. Gene Oracle Recent Development Table 52. SBS Genetech Company Information Table 53. SBS Genetech Business Overview Table 54. SBS Genetech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio Table 56. SBS Genetech Recent Development Table 57. Creative Biolabs Company Information Table 58. Creative Biolabs Business Overview Table 59. Creative Biolabs DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio Table 61. Creative Biolabs Recent Development Table 62. Bio Basic Company Information Table 63. Bio Basic Business Overview Table 64. Bio Basic DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio Table 66. Bio Basic Recent Development Table 67. Kaneka Eurogentec SA Company Information Table 68. Kaneka Eurogentec SA Business Overview Table 69. Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio Table 71. Kaneka Eurogentec SA Recent Development Table 72. AltaBioscience Company Information Table 73. AltaBioscience Business Overview Table 74. AltaBioscience DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio Table 76. AltaBioscience Recent Development Table 77. Synbio Technologies Company Information Table 78. Synbio Technologies Business Overview Table 79. Synbio Technologies DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio Table 81. Synbio Technologies Recent Development Table 82. TriLink Company Information Table 83. TriLink Business Overview Table 84. TriLink DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. TriLink DNA Oligonucleotide Synthesis Service Product Portfolio Table 86. TriLink Recent Development Table 87. Azenta Life Science Company Information Table 88. Azenta Life Science Business Overview Table 89. Azenta Life Science DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio Table 91. Azenta Life Science Recent Development Table 92. KareBay Biochem Company Information Table 93. KareBay Biochem Business Overview Table 94. KareBay Biochem DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio Table 96. KareBay Biochem Recent Development Table 97. Creative Biogene Company Information Table 98. Creative Biogene Business Overview Table 99. Creative Biogene DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio Table 101. Creative Biogene Recent Development Table 102. Generi Biotech Company Information Table 103. Generi Biotech Business Overview Table 104. Generi Biotech DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio Table 106. Generi Biotech Recent Development Table 107. Primetech Company Information Table 108. Primetech Business Overview Table 109. Primetech DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Primetech DNA Oligonucleotide Synthesis Service Product Portfolio Table 111. Primetech Recent Development Table 112. General Biosystems Company Information Table 113. General Biosystems Business Overview Table 114. General Biosystems DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio Table 116. General Biosystems Recent Development Table 117. GenScript Company Information Table 118. GenScript Business Overview Table 119. GenScript DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. GenScript DNA Oligonucleotide Synthesis Service Product Portfolio Table 121. GenScript Recent Development Table 122. OriGene Company Information Table 123. OriGene Business Overview Table 124. OriGene DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. OriGene DNA Oligonucleotide Synthesis Service Product Portfolio Table 126. OriGene Recent Development Table 127. BBI Company Information Table 128. BBI Business Overview Table 129. BBI DNA Oligonucleotide Synthesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. BBI DNA Oligonucleotide Synthesis Service Product Portfolio Table 131. BBI Recent Development Table 132. North America DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 133. North America DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 134. North America DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 135. North America DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 136. North America DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 138. North America DNA Oligonucleotide Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 139. Europe DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 145. Europe DNA Oligonucleotide Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 146. China DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 147. China DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 148. China DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 149. China DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia DNA Oligonucleotide Synthesis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia DNA Oligonucleotide Synthesis Service Revenue by Region (US$ Million) & (2021-2026) Table 156. Asia DNA Oligonucleotide Synthesis Service Revenue by Region (US$ Million) & (2027-2032) Table 157. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026) & (US$ Million) Table 163. SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (US$ Million) & (2027-2032) Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. DNA Oligonucleotide Synthesis Service Image Figure 2. Global DNA Oligonucleotide Synthesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Oligonucleotide Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Standard Oligonucleotides Image Figure 5. Micro-Oligonucleotides Image Figure 6. Large-scale Oligonucleotides Image Figure 7. Degenerate Primers Image Figure 8. Long Oligos Synthesis Image Figure 9. Global DNA Oligonucleotide Synthesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global DNA Oligonucleotide Synthesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 11. Commercial Image Figure 12. Academic Research Image Figure 13. Global DNA Oligonucleotide Synthesis Service Market Size (US$ Million) & (2021-2032) Figure 14. Global DNA Oligonucleotide Synthesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global DNA Oligonucleotide Synthesis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global DNA Oligonucleotide Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global DNA Oligonucleotide Synthesis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global DNA Oligonucleotide Synthesis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Type (2021-2032) Figure 21. Global DNA Oligonucleotide Synthesis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Application (2021-2032) Figure 24. North America DNA Oligonucleotide Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032) Figure 26. North America DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032) Figure 27. North America DNA Oligonucleotide Synthesis Service Revenue Share by Country (2021-2032) Figure 28. United States DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe DNA Oligonucleotide Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032) Figure 33. Europe DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032) Figure 34. Europe DNA Oligonucleotide Synthesis Service Revenue Share by Country (2021-2032) Figure 35. Germany DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China DNA Oligonucleotide Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032) Figure 45. China DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032) Figure 46. Asia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032) Figure 48. Asia DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032) Figure 49. Asia DNA Oligonucleotide Synthesis Service Revenue Share by Region (2021-2032) Figure 50. Japan DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA DNA Oligonucleotide Synthesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032) Figure 58. SAMEA DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032) Figure 59. SAMEA DNA Oligonucleotide Synthesis Service Revenue Share by Country (2021-2032) Figure 60. Brazil DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt DNA Oligonucleotide Synthesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Oligonucleotides
  • Micro-Oligonucleotides
  • Large-scale Oligonucleotides
  • Degenerate Primers
  • Long Oligos Synthesis
Applications
  • Commercial
  • Academic Research
Companies covered
  • Genewiz
  • Eurofins Genomics
  • Gene Oracle
  • SBS Genetech
  • Creative Biolabs
  • Bio Basic
  • Kaneka Eurogentec SA
  • AltaBioscience
  • Synbio Technologies
  • TriLink
  • Azenta Life Science
  • KareBay Biochem
  • Creative Biogene
  • Generi Biotech
  • Primetech
  • General Biosystems
  • GenScript
  • OriGene
  • BBI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Oligonucleotide Synthesis Service Market by Type
  3. 1.2.1 Global DNA Oligonucleotide Synthesis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Standard Oligonucleotides
  5. 1.2.3 Micro-Oligonucleotides
  6. 1.2.4 Large-scale Oligonucleotides
  7. 1.2.5 Degenerate Primers
  8. 1.2.6 Long Oligos Synthesis
  9. 1.3 DNA Oligonucleotide Synthesis Service Market by Application
  10. 1.3.1 Global DNA Oligonucleotide Synthesis Service Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Commercial
  12. 1.3.3 Academic Research
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 DNA Oligonucleotide Synthesis Service Market Dynamics
  1. 2.1 DNA Oligonucleotide Synthesis Service Industry Trends
  2. 2.2 DNA Oligonucleotide Synthesis Service Industry Drivers
  3. 2.3 DNA Oligonucleotide Synthesis Service Industry Opportunities and Challenges
  4. 2.4 DNA Oligonucleotide Synthesis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global DNA Oligonucleotide Synthesis Service Market Perspective (2021-2032)
  2. 3.2 Global DNA Oligonucleotide Synthesis Service Growth Trends by Region
  3. 3.2.1 Global DNA Oligonucleotide Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Oligonucleotide Synthesis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global DNA Oligonucleotide Synthesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global DNA Oligonucleotide Synthesis Service Revenue by Players
  2. 4.1.1 Global DNA Oligonucleotide Synthesis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global DNA Oligonucleotide Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Oligonucleotide Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global DNA Oligonucleotide Synthesis Service Key Players Headquarters & Area Served
  7. 4.4 Global DNA Oligonucleotide Synthesis Service Players, Product Type & Application
  8. 4.5 Global DNA Oligonucleotide Synthesis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global DNA Oligonucleotide Synthesis Service Market CR5 and HHI
  11. 4.6.3 2025 DNA Oligonucleotide Synthesis Service Tier 1, Tier 2, and Tier 3
5 DNA Oligonucleotide Synthesis Service Market Size by Type
  1. 5.1 Global DNA Oligonucleotide Synthesis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 5.3 Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Type (2021-2032)
6 DNA Oligonucleotide Synthesis Service Market Size by Application
  1. 6.1 Global DNA Oligonucleotide Synthesis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  3. 6.3 Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Genewiz
  2. 7.1.1 Genewiz Company Information
  3. 7.1.2 Genewiz Business Overview
  4. 7.1.3 Genewiz DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio
  6. 7.1.5 Genewiz Recent Developments
  7. 7.2 Eurofins Genomics
  8. 7.2.1 Eurofins Genomics Company Information
  9. 7.2.2 Eurofins Genomics Business Overview
  10. 7.2.3 Eurofins Genomics DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio
  12. 7.2.5 Eurofins Genomics Recent Developments
  13. 7.3 Gene Oracle
  14. 7.3.1 Gene Oracle Company Information
  15. 7.3.2 Gene Oracle Business Overview
  16. 7.3.3 Gene Oracle DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio
  18. 7.3.5 Gene Oracle Recent Developments
  19. 7.4 SBS Genetech
  20. 7.4.1 SBS Genetech Company Information
  21. 7.4.2 SBS Genetech Business Overview
  22. 7.4.3 SBS Genetech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio
  24. 7.4.5 SBS Genetech Recent Developments
  25. 7.5 Creative Biolabs
  26. 7.5.1 Creative Biolabs Company Information
  27. 7.5.2 Creative Biolabs Business Overview
  28. 7.5.3 Creative Biolabs DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio
  30. 7.5.5 Creative Biolabs Recent Developments
  31. 7.6 Bio Basic
  32. 7.6.1 Bio Basic Company Information
  33. 7.6.2 Bio Basic Business Overview
  34. 7.6.3 Bio Basic DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio
  36. 7.6.5 Bio Basic Recent Developments
  37. 7.7 Kaneka Eurogentec SA
  38. 7.7.1 Kaneka Eurogentec SA Company Information
  39. 7.7.2 Kaneka Eurogentec SA Business Overview
  40. 7.7.3 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio
  42. 7.7.5 Kaneka Eurogentec SA Recent Developments
  43. 7.8 AltaBioscience
  44. 7.8.1 AltaBioscience Company Information
  45. 7.8.2 AltaBioscience Business Overview
  46. 7.8.3 AltaBioscience DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio
  48. 7.8.5 AltaBioscience Recent Developments
  49. 7.9 Synbio Technologies
  50. 7.9.1 Synbio Technologies Company Information
  51. 7.9.2 Synbio Technologies Business Overview
  52. 7.9.3 Synbio Technologies DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio
  54. 7.9.5 Synbio Technologies Recent Developments
  55. 7.10 TriLink
  56. 7.10.1 TriLink Company Information
  57. 7.10.2 TriLink Business Overview
  58. 7.10.3 TriLink DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 TriLink DNA Oligonucleotide Synthesis Service Product Portfolio
  60. 7.10.5 TriLink Recent Developments
  61. 7.11 Azenta Life Science
  62. 7.11.1 Azenta Life Science Company Information
  63. 7.11.2 Azenta Life Science Business Overview
  64. 7.11.3 Azenta Life Science DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio
  66. 7.11.5 Azenta Life Science Recent Developments
  67. 7.12 KareBay Biochem
  68. 7.12.1 KareBay Biochem Company Information
  69. 7.12.2 KareBay Biochem Business Overview
  70. 7.12.3 KareBay Biochem DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio
  72. 7.12.5 KareBay Biochem Recent Developments
  73. 7.13 Creative Biogene
  74. 7.13.1 Creative Biogene Company Information
  75. 7.13.2 Creative Biogene Business Overview
  76. 7.13.3 Creative Biogene DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio
  78. 7.13.5 Creative Biogene Recent Developments
  79. 7.14 Generi Biotech
  80. 7.14.1 Generi Biotech Company Information
  81. 7.14.2 Generi Biotech Business Overview
  82. 7.14.3 Generi Biotech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio
  84. 7.14.5 Generi Biotech Recent Developments
  85. 7.15 Primetech
  86. 7.15.1 Primetech Company Information
  87. 7.15.2 Primetech Business Overview
  88. 7.15.3 Primetech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Primetech DNA Oligonucleotide Synthesis Service Product Portfolio
  90. 7.15.5 Primetech Recent Developments
  91. 7.16 General Biosystems
  92. 7.16.1 General Biosystems Company Information
  93. 7.16.2 General Biosystems Business Overview
  94. 7.16.3 General Biosystems DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio
  96. 7.16.5 General Biosystems Recent Developments
  97. 7.17 GenScript
  98. 7.17.1 GenScript Company Information
  99. 7.17.2 GenScript Business Overview
  100. 7.17.3 GenScript DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 GenScript DNA Oligonucleotide Synthesis Service Product Portfolio
  102. 7.17.5 GenScript Recent Developments
  103. 7.18 OriGene
  104. 7.18.1 OriGene Company Information
  105. 7.18.2 OriGene Business Overview
  106. 7.18.3 OriGene DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 OriGene DNA Oligonucleotide Synthesis Service Product Portfolio
  108. 7.18.5 OriGene Recent Developments
  109. 7.19 BBI
  110. 7.19.1 BBI Company Information
  111. 7.19.2 BBI Business Overview
  112. 7.19.3 BBI DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 BBI DNA Oligonucleotide Synthesis Service Product Portfolio
  114. 7.19.5 BBI Recent Developments
8 North America
  1. 8.1 North America DNA Oligonucleotide Synthesis Service Revenue (2021-2032)
  2. 8.2 North America DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032)
  5. 8.3 North America DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032)
  9. 8.5 North America DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America DNA Oligonucleotide Synthesis Service Revenue by Country
  11. 8.6.1 North America DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America DNA Oligonucleotide Synthesis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe DNA Oligonucleotide Synthesis Service Revenue (2021-2032)
  2. 9.2 Europe DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032)
  5. 9.3 Europe DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032)
  9. 9.5 Europe DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe DNA Oligonucleotide Synthesis Service Revenue by Country
  11. 9.6.1 Europe DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe DNA Oligonucleotide Synthesis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China DNA Oligonucleotide Synthesis Service Revenue (2021-2032)
  2. 10.2 China DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 10.2.1 China DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026)
  4. 10.2.2 China DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032)
  5. 10.3 China DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032)
  6. 10.4 China DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  7. 10.4.1 China DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026)
  8. 10.4.2 China DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032)
  9. 10.5 China DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Oligonucleotide Synthesis Service Revenue (2021-2032)
  2. 11.2 Asia DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032)
  5. 11.3 Asia DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032)
  9. 11.5 Asia DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia DNA Oligonucleotide Synthesis Service Revenue by Country
  11. 11.6.1 Asia DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia DNA Oligonucleotide Synthesis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Oligonucleotide Synthesis Service Revenue (2021-2032)
  2. 12.2 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA DNA Oligonucleotide Synthesis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA DNA Oligonucleotide Synthesis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country
  11. 12.6.1 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA DNA Oligonucleotide Synthesis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst